摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(4-fluorophenyl)-1-hydroxypropan-2-one

中文名称
——
中文别名
——
英文名称
1-(4-fluorophenyl)-1-hydroxypropan-2-one
英文别名
4-fluorophenylacetyl carbinol;(+/-)-1-(4-Fluor-phenyl)-propan-1-ol-2-on;1-hydroxy-1-(4-fluorophenyl)-propan-2-one;1-(4-fluorophenyl)-1-hydroxyacetone
1-(4-fluorophenyl)-1-hydroxypropan-2-one化学式
CAS
——
化学式
C9H9FO2
mdl
——
分子量
168.168
InChiKey
YBZCHZLXSYLQNU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.1
  • 重原子数:
    12
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(4-fluorophenyl)-1-hydroxypropan-2-one甲酸 、 RhCl[(R,R)-TsDPEN](C5Me5) 、 氨基磺酰氯对甲苯磺酸三乙胺 作用下, 以 N,N-二甲基乙酰胺乙酸乙酯甲苯 为溶剂, 反应 1.75h, 生成 (4S,5R)-5-(4-fluorophenyl)-4-methyl-[1,2,3]oxathiazolidine 2,2-dioxide
    参考文献:
    名称:
    Stereoselective Synthesis of Norephedrine and Norpseudoephedrine by Using Asymmetric Transfer Hydrogenation Accompanied by Dynamic Kinetic Resolution
    摘要:
    Each of the enantiomers of both norephedrine and norpseudoephedrine were stereoselectively prepared from the common, prochiral cyclic sulfamidate imine of racemic 1-hydroxy-1-phenyl-propan-2-one by employing asymmetric transfer hydrogenation (ATH) catalyzed by the well-defined chiral Rh-complexes, (S,S)- or (R,R)-Cp*RhCl(TsDPEN), and HCO2H/Et3N as the hydrogen source. The ATH processes are carried out under mild conditions (rt, 15 min) and are accompanied by dynamic kinetic resolution.
    DOI:
    10.1021/jo300867y
  • 作为产物:
    参考文献:
    名称:
    Weichet,J. et al., Collection of Czechoslovak Chemical Communications, 1961, vol. 26, p. 2040 - 2044
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • FUNGICIDAL MIXTURES
    申请人:Gregory Vann
    公开号:US20100240619A1
    公开(公告)日:2010-09-23
    Disclosed is a fungicidal composition comprising (a) at least one compound selected from the compounds of Formula 1 N-oxides, and salts thereof, wherein R 1 , R 2 , A, G, W, Z 1 , X, J, and n are as defined in the disclosure, and (b) at least one additional fungicidal compound. Also disclosed is a method for controlling plant diseases caused by fungal plant pathogens comprising applying to the plant or portion thereof, or to the plant seed, a fungicidally effective amount of the aforesaid composition. Also disclosed is a composition comprising component (a) of aforesaid composition and at least one insecticide. Also disclosed are compounds of Formula 1A, 1B and 1C, wherein R 1 , R 2 , A, G, W, Z 1 , X, J, n, Z 3 , M and J 1 are as defined in the disclosure.
    公开了一种含真菌化合物,包括:(a)至少一种选自公式1 N-氧化物的化合物,以及它们的盐类,其中R1,R2,A,G,W,Z1,X,J和n如公开所述定义,以及(b)至少一种额外的含真菌化合物。还公开了一种控制由真菌植物病原体引起的植物病害的方法,包括将有效量的前述组合物施用于植物或其部分,或施用于植物种子。还公开了一种组合物,包括前述组合物的组分(a)和至少一种杀虫剂。还公开了公式1A,1B和1C的化合物,其中R1,R2,A,G,W,Z1,X,J,n,Z3,M和J1如公开所述定义。
  • Base-Promoted Three-Component Cascade Reaction of α-Hydroxy Ketones, Malonodinitrile, and Alcohols: Direct Access to Tetrasubstituted N<i>H</i>-Pyrroles
    作者:Hongjian Liu、Chaorong Qi、Lu Wang、Yanhui Guo、Dan Li、Huanfeng Jiang
    DOI:10.1021/acs.joc.1c00882
    日期:2021.7.16
    malonodinitrile, and alcohols has been developed, providing a direct and efficient route to a range of structurally diverse and synthetically useful 2-alkyloxy-1H-pyrrole-3-carbonitrile derivatives. The reaction involved three different bond (C–C, C–O, and C–N) formations in a single step, and its regioselectivity was depended on the structure of the α-hydroxy ketones employed. The use of easily available
    已经开发了 α-羟基酮、丙二腈和醇的碱促进三组分级联反应,为一系列结构多样且合成有用的 2-烷氧基-1 H-吡咯-3-腈提供了直接有效的途径衍生品。该反应在一个步骤中涉及三种不同的键(C-C、C-O 和 C-N)的形成,其区域选择性取决于所使用的 α-羟基酮的结构。使用容易获得的起始材料、广泛的底物范围、良好的官能团耐受性、操作简单和高原子经济性是新方法的吸引人的特点。
  • [EN] CETP INHIBITORS<br/>[FR] INHIBITEURS DE LA CETP
    申请人:MERCK & CO INC
    公开号:WO2006014357A1
    公开(公告)日:2006-02-09
    Compounds having the structures of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis: In the compounds of Formula I, B or R2 is a phenyl group which has an ortho aryl, heterocyclic, benzoheterocyclic or benzocycloalky substituent, and one other position on the 5-membered ring has an aromatic, heterocyclic, cycloalkyl, benzoheterocyclic or benzocycloalky substituent connected directly to the ring or attached to the ring through a -CH2-.
    具有公式I结构的化合物,包括这些化合物的药用盐,是CETP抑制剂,可用于提高HDL-胆固醇,降低LDL-胆固醇,并用于治疗或预防动脉粥样硬化:在公式I的化合物中,B或R2是具有邻位芳基、杂环、苯并杂环或苯环烷基取代基的苯基,而5-成员环的另一个位置具有直接连接到环或通过-CH2-连接到环的芳基、杂环、环烷基、苯并杂环或苯环烷基取代基。
  • CETP inhibitors
    申请人:Ali Amjad
    公开号:US20060040999A1
    公开(公告)日:2006-02-23
    Compounds having the structures of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis: In the compounds of Formula I, B or R 2 is a phenyl group which has an ortho aryl, heterocyclic, benzoheterocyclic or benzocycloalkyl substituent, and one other position on the 5-membered ring has an aromatic, heterocyclic, cycloalkyl, benzoheterocyclic or benzocycloalkyl substituent connected directly to the ring or attached to the ring through a —CH 2 —.
    具有I式结构的化合物,包括该化合物的药学可接受的盐,是CETP抑制剂,可用于提高高密度脂蛋白胆固醇,降低低密度脂蛋白胆固醇,以及治疗或预防动脉粥样硬化:在I式化合物中,B或R2是具有正交芳基,杂环,苯并杂环或苯并环烷基取代基的苯基取代基,并且5元环上的另一个位置具有芳香,杂环,环烷基,苯并杂环或苯并环烷基取代基,直接连接到环或通过—CH2—连接到环。
  • Cetp Inhibitors
    申请人:Ali Amjad
    公开号:US20080119476A1
    公开(公告)日:2008-05-22
    Compounds having the structures of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis: In the compounds of Formula I, B or R 2 is a phenyl group which has an ortho aryl, heterocyclic, benzoheterocyclic or benzocycloalkyl substituent, and one other position on the 5-membered ring has an aromatic, heterocyclic, cycloalkyl, benzoheterocyclic or benzocycloalkyl substituent connected directly to the ring or attached to the ring through a —CH 2 —.
    具有公式I结构的化合物,包括化合物的药物可接受的盐,是CETP抑制剂,可用于提高HDL-胆固醇,降低LDL-胆固醇,以及治疗或预防动脉粥样硬化。在公式I的化合物中,B或R2是具有正交芳基,杂环,苯并杂环或苯并环烷基取代基的苯基基团,5元环上的另一个位置具有芳基,杂环,环烷基,苯并杂环或苯并环烷基取代基,直接连接到环或通过-CH2-附加到环上。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐